副总裁，美国销售与市场
Vice President, US Sales & Marketing
我们是一家快速发展的医疗设备公司，致力于为介入心脏病学和结构性心脏手术开发先进的医疗器械软件（SaMD）解决方案。我们的核心技术将实时荧光透视与术前3D CT标注相结合，提供精确的术中指导，提高安全性和临床效果。
我们的创新融合了CT预处理、荧光透视预处理、AI驱动的检测与跟踪、解剖标志点检测，以及基于个性化数字重建影像（DRR）的网络训练，结合最前沿的配准协议。我们拥有一个小型、高技能的内部工程团队，并由分布在多个大洲的专业承包商进行补充。
美国销售与市场副总裁
CARA Medical — 美国商业运营
汇报对象：CEO | 地点：美国，远程办公，靠近主要机场；约60%出差
关于CARA Medical
CARA Medical是一家初创的SaMD公司，支持心脏传导系统附近或针对该系统的干预术前规划和术中导航。例如，结构性心脏手术（如TAVR、TTVR）中，我们的技术可以帮助医生避免传导系统损伤；在传导系统起搏（CSP）中，可以帮助操作者到达传导系统以放置起搏电极。
职责
建立并领导CARA的美国商业职能，从零开始：在TAVR和传导系统起搏中推出CARA系统（Metis、Atlas、CGI），建立推动采用的KOL和中心网络，并招募和管理一支小型、专注的销售团队。这是一个从零开始定义新的传导引导干预类别如何进入美国市场的绝佳机会，并为公司构建可扩展的商业基础。
职责
销售
· 制定并提交批准美国商业策略、运营计划和预算
- 领导美国商业发布和收入增长，在建立销售组织之前亲自推进初始销售工作。
- 识别、开拓并完成初始中心（TAVR和EP/CSP项目）；管理资本和按例次的商业模型。
- 招募、培训和管理最小的销售团队；与CEO**共同定义区域划分和薪酬。
- 协调商业运营，主导医院合同、价值分析委员会以及GPO/IDN参与。
- 管理美国商业预算，确保支出符合批准的公司计划和优先事项
市场
· 定义定位
查看英文原文
We are a fast-growing medical device company developing advanced Software as a Medical Device (SaMD) solutions for interventional cardiology and structural heart procedures. Our flagship technology integrates real-time fluoroscopy with pre-procedure 3D CT annotations to provide precise intra-procedural guidance, enhancing safety and clinical outcomes.
Our innovation combines CT preprocessing, fluoroscopy preprocessing, AI-driven detection and tracking, anatomical landmark detection, and personalized DRR-based network training with cutting-edge registration protocols. We operate with a small, highly skilled in-house engineering team, supplemented by specialized contractors across several continents.
Vice President, US Sales & Marketing
CARA Medical — US Commercial Operation
Reports to: CEO** | Location: US, remote, near a major airport; ~60% travel
About CARA Medical
CARA Medical is a startup SaMD that supports pre procedure planning and intra procedure navigation for interventions near or targeting the cardiac conduction system. Example use cases include structural heart procedures (e.g., TAVR, TTVR) where our technology can help physicians avoid conduction system injury, and Conduction System Pacing (CSP) where it can help operators reach the conduction system to place a pacing lead.
Purpose
Build and lead CARA's US commercial function from near zero: launch the CARA System (Metis, Atlas, CGI) in TAVR and conduction system pacing, establish the KOL and center network that drives adoption, and recruit and manage a small, focused sales team. This is a ground-floor opportunity to define how a new category of conduction-guided intervention enters the US market, and to build the commercial foundation the company will scale on.
Responsibilities
Sales
· Develop and present for approval the US commercial strategy, operating plan, and budget
- Drive the US commercial launch and revenue growth, leading the initial sales effort personally before building out the sales organization.
- Identify, open, and close initial centers (TAVR and EP/CSP programs); manage capital and per-procedure commercial models.
- Recruit, train, and manage a minimal sales force; define territories and compensation with the CEO**.
- Lead hospital contracting, value-analysis committees, and GPO/IDN engagement in coordination with Commercial Operations.
- Manage the US commercial budget and ensure spending is aligned with approved company plans and priorities
Marketing
- Define positioning and messaging for interventional cardiology, electrophysiology, and hospital administration audiences.
- Plan and execute presence at TCT, HRS, ACC, and relevant CSP/structural-heart meetings.
- Direct collateral, case studies, and digital content; manage external agencies where required.
KOL and clinical engagement
- Maintain and extend personal relationships with TAVR and EP/CSP opinion leaders; secure early adopters, podium presence, and clinical champions.
- Coordinate with Clinical Engineers (CPE-certified) and the Valencia imaging center on case support and site onboarding.
Commercial planning
- Build forecast, pipeline, and CRM discipline appropriate to company scale.
- Report monthly to the CEO**on pipeline, conversions, and market feedback; feed clinical and product insight back to R&D and regulatory.
Required
- 12+ years in US cardiovascular device sales, with at least 5 in a sales leadership role (Regional/Area Director or above).
- Demonstrable personal network among EP/CSP opinion leaders and implanting physicians; established relationships with structural heart/TAVR operators strongly preferred.
- Track record of launching a new technology or opening a new indication, not solely managing a mature franchise.
- Experience with capital and disposable sales models, hospital value analysis, and GPO/IDN contracting.
- Comfortable operating with limited infrastructure writes the plan, executes it, and hires behind it.
Preferred
- Prior experience at a venture-backed device company through first US launch.
- Familiarity with cardiac imaging (CT-based planning) or mapping systems.
- Marketing ownership in a previous role.
First 12 months — success measures
- Launch plan approved and executing within 90 days.
- Target early-adopter centers contracted and live (number to be set with CEO**).
- Sales team of 3 regional managers hired trained, and managed.
- KOL advisory group established; first podium/abstract presence secured.
Compensation
Competitive compensation, commensurate with experience.
[Base + variable + equity — to be set.]
** - until CEO is hired, report to the board of directors or any other person designated by the board.
We are currently expanding our team. As a start-up, we are fast paced and have a shared goal to succeed in developing unmet healthcare needs in the most efficient way. If you share this vision and are interested in joining us - please apply. We look forward to hearing from you.
Originally posted on Himalayas